VKTX
Viking Therapeutics Inc
27.70$
-2.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +1.4% | +0.0% | +1.4% | +16.0% | +26.4% | – | – | +1.8% | -17.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.6% | +17.6% | -1.4% | -4.1% | +36.0% | +33.6% | +45.3% | +49.5% | +70.6% | -2.2% | -22.9% | – | |
| – | -1.2% | +13.5% | +3.2% | +33.9% | +10.7% | -7.7% | +2.4% | -40.3% | +31.0% | +23.9% | +20.5% | – | |
| – | +7.4% | +16.3% | -0.1% | +7.3% | +26.5% | +20.0% | +34.4% | +32.2% | +67.1% | -0.4% | -19.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,200.0% | +7.7% | -35.7% | +33.3% | +0.0% | +0.0% | +0.0% | -66.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -97.3% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.